Online Program Home
My Program

Abstract Details

Activity Number: 704
Type: Contributed
Date/Time: Thursday, August 4, 2016 : 10:30 AM to 12:20 PM
Sponsor: Biopharmaceutical Section
Abstract #318941 View Presentation
Title: Defensive Efficacy Interim Design: Dynamic Benefit/Risk Ratio View Using Probability of Success
Author(s): Zhongwen Tang*
Companies: Novartis
Keywords: probability of success ; defensive design ; composite end point ; media end point ; dynamic view ; benefit/risk ratio
Abstract:

Traditional efficacy interim design is based on alpha spending which doesn't have intuitive interpretation and hence is difficult to communicate with non-statistician colleagues. The alpha spending approach is based on efficacy alone and hence doesn't have the flexibility to incorporate newly emerged safety signal. Newly emerged safety signal may nullify the originally set efficacy boundary. In contrast, the probability of success (POS) concept has intuitive interpretation and hence can facilitate our communication with non-statistician colleagues and help to obtain health authorities (HA) buying. The success criteria of POS is not restricted to statistical significance. Hence POS has the capability to incorporate both efficacy and safety information. We propose to use POS and its credible interval to design efficacy interim. In the proposed method, the efficacy boundary is adjustable to offset newly emerged safety signal. (reference: http://www.tandfonline.com/doi/full/10.1080/10543406.2014.983646)


Authors who are presenting talks have a * after their name.

Back to the full JSM 2016 program

 
 
Copyright © American Statistical Association